Nubia-Paola Forero-Medina
Internal Medicine · San Antonio, TXNPI 1346553146
Payments from drug & device makers
Across 85 payments — averaging $25.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$507
- Lilly USA, LLC$338
- AstraZeneca$301
- Bayer$185
- Boehringer Ingelheim$181
- Sumitomo Pharma America, Inc.$141
- plus $537 from 14 others
What the payments were for
- Food & beverage$2,191100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 13 | $507 |
| Lilly USA, LLC | 13 | $338 |
| AstraZeneca | 11 | $301 |
| Bayer | 6 | $185 |
| Boehringer Ingelheim | 8 | $181 |
| Sumitomo Pharma America, Inc. | 7 | $141 |
| Dexcom, Inc. | 6 | $139 |
| Sanofi-aventis U.S. LLC | 6 | $112 |
| AbbVie | 2 | $53 |
| Phathom Pharmaceuticals, Inc. | 3 | $45 |
| Sanofi Pasteur Inc. | 1 | $25 |
| Philips North America LLC | 1 | $23 |
| Abbott | 1 | $23 |
| Amgen | 1 | $21 |
| GSK | 1 | $21 |
| Merck | 1 | $18 |
| Novartis | 1 | $16 |
| Dynavax Technologies Corporation | 1 | $15 |
| Mannkind Corporation | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,191 in reported general payments places this provider in the 75th percentile of 7,675 internal medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 107 | $182,204 |
| OzempicSemaglutide | 78 | $167,412 |
| JanuviaSitagliptin Phosphate | 44 | $51,871 |
| EliquisApixaban | 32 | $44,816 |
| MyrbetriqMirabegron | 27 | $33,194 |
| TrulicityDulaglutide | 16 | $29,714 |
| LinzessLinaclotide | 15 | $24,131 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 11 | $17,097 |
| Advair HfaFluticasone Propion/Salmeterol | 32 | $16,971 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $16,243 |
| Breo ElliptaFluticasone/Vilanterol | 20 | $14,528 |
| SymbicortBudesonide/Formoterol Fumarate | 23 | $9,124 |
| Rosuvastatin Calcium | 359 | $8,039 |
| Duloxetine Hcl | 183 | $4,735 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 114 | $4,707 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $181 | $182,204107 claims |
| Novo NordiskOzempic | $507 | $167,41278 claims |
| MerckJanuvia, Janumet Xr | $18 | $68,96755 claims |
| Lilly USA, LLCTrulicity | $338 | $29,71416 claims |
| AbbVieLinzess | $53 | $24,13115 claims |
| GSKBreo Ellipta | $21 | $14,52820 claims |
| AstraZenecaSymbicort | $301 | $9,12423 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 7,675 internal medicine providers in Texas.
Other internal medicine in San Antonio
- Robert BassSan Antonio$25.6M
- Hernan SalazarSan Antonio$18.5M
- Dennis RuffSan Antonio$7.5M
- Cassandra KeySan Antonio$5.6M
- Jan BurgerHouston$47.3M
- Nitin JainHouston$33.2M
- Muhammad IrfanTomball$30.6M
- Aung NaingHouston$30.6M
- Preetesh JainHouston$19.5M
- Paolo StratiHouston$19.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.